 |
|
|
| |
De Novo MASLD and Metabolic Outcomes Following DAA-Mediated HCV Eradication: A Propensity Score-Matched Cohort Analysis
|
| |
| |
AASLD 2026 Nov 5-8 Denver
J. JOHAL1, O. PATEL1, A. HUSSEIN1, M. AL-BATAINEH1, Y. SCHNEIDER1 and J. HYMAN2
1. Virtua Health, Camden, NJ, USA 2. Einstein Medical Center, Philadelphia, PA, USA
|
| |
|
|
|
|
|
